atum logo
atum logo
What we do
Catalog
Resources
中文
Contact

News and Events

news

2021-12-01
Will we be protected from COVID-19’s omicron variant? Bay Area researchers sprint to find out
2021-03-19
Inom en timme hade vi tio rush-orders
2021-03-19
Fighting for Our Lives
2020-07-26
Biotech firm rebounds to combat coronavirus
2020-07-22
Big Heroes of Small Business: This Biotech Business Won't Let Cost Get in the Way of a Covid Cure
2020-07-06
Debottlenecking Opportunities Clearer with a Bioprocessing 4.0 Perspective
2020-06-17
Race for a vaccine: Synthetic COVID-19 viruses, built from scratch in the Bay Area, fuel critical research
2020-06-16
Realizing the Virtues of Virtual
2020-06-09
Interdisciplinary scientific collaboration at Stanford: Developing an antibody test for COVID-19
2020-03-19
Some Progress Made in Push to Find Coronavirus Treatment
2020-03-19
Coronavirus Special with Stanford's Dr John Ioannadis and ATUM's Claes Gustafsson
2020-03-02
Bay Area Tech Companies Look for Coronavirus Treatment
2020-02-18
Leap into Efficient Cell Lines
2019-09-03
Leap-In Transposases and Transposons Accelerate Cell Line Development
2019-06-12
California sun and $1.5m investment help ATUM go green
2019-04-16
ATUM: genetic bio-engineers
2019-02-20
Unleashing terror? How to catch deadly mail-order DNA
2018-02-02
AI Could Revolutionize Gene Therapy
2017-10-15
Screening to Small-Scale GMP Biomanufacture
2017-10-01
Protein Protential
2017-10-01
Designer Computational tools for mapping out synthetic nucleic acids
2017-04-12
Speed, yield and quality critical for cell line development, says ATUM, By Dan Stanton
2017-04-10
Building Biology with Machine Learning
2016-08-11
Synthetic Human Genome Set to Spur Applications
2016-01-15
Systems Biology Finally CHO-Ready
2015-01-15
Getunte Gene (Tuned Gene)
2014-06-17
Engineering the Future: The world struggles to keep up with the pace of change in science and technology
2014-02-24
Don't Get Hung Up On Gene Synthesis
2013-10-01
CROs: Is Yours Meeting Your Needs?
2013-07-03
Bioengineers look beyond patents: Synthetic-biology company pushes open source models.
2013-06-24
Make Mine a Double Helix
2013-06-15
Nudging Difficult-to-Express Proteins Along
2013-06-15
Rapid, Scarless Cloning of Gene Fragments Using the Electra Vector System®
2013-04-15
Library Format for Bioengineering: Maximizing Screening Efficiency through Good Design
2013-02-17
Synthetic biology: Stanford, UC Berkeley engineering a new frontier
2013-02-05
Dan Rather Reports - Cutting Edge
2013-02-04
Delivering the DNA - Despite its troubled past, gene therapy finds some traction in HIV prevention research
2013-01-01
Twisting and Turning for Better Protein Expression
2012-11-14
Optimizing Gene Expression with DNA2.0 Technology
2012-07-01
Move Over, Mother Nature. Synthetic biologists harness software to design genes and networks.
2012-03-15
Harnessing Innovation to Improve Expression Systems.
2012-03-01
Pfenex and DNA2.0 Ally to Improve Protein Expression Technology.
2012-02-22
Cosmo Bio Distributing DNA2.0 Products in Japan.
2012-02-03
Protein Variant Libraries.
2011-12-16
SBOL Developers aim to standardize information exchange for computer-aided Gene Design.
2011-12-06
Breaking the Silence - Nature Medicine examines synonymous mutations, gene optimization and DNA2.0.
2011-08-25
USPTO Patent Provided for ProteinGPS.
2011-02-23
DNA2.0 Secures NSF Grant to Extend Gene Optimization Algorithms to Mammalian Protein Production.
2011-01-01
Increasing protein expression, including DNA2.0's Mark Welch on synthetic gene redesign for optimal expression.
2010-08-03
DNA2.0's Jeremy Minshull comments on government Biosecurity recommendations for a sequence-based system of identifying pathogens.
2010-06-17
DNA2.0 has launched Gene Designer 2.0, a free software tool for designing novel DNA sequences.
2010-05-20
DNA2.0 and Blue Sky Biotech form a strategic alliance to provide integrated gene synthesis and protein expression and purification services.
2010-05-20
DNA2.0 and Blue Sky Biotech join forces to provide customers with a seamless experience from gene synthesis to protein expression and purification services.
2010-05-01
The synthetic side of protein expression and Dr. Mark Welch's research on what actually works for designing synthetic genes to express.
2010-05-01
Dr Mark Welch describes the gene re-coding algorithms developed by DNA2.0 as a generic solution to difficult-to-express-proteins.
2010-01-08
With the licensing of Virginia Tech's GenoCAD software, ISCB encourages a user and development community for open source bioinformatics software. DNA2.0 continues its strong support and involvement.
2009-12-01
The DNA2.0 gene optimization technology is picked by The Scientist as Top Ten Innovations of 2009 - The ten most exciting tools to hit the life sciences this year.
2009-12-01
What's in a name? Defining an emerging field can be challenging. Nature Biotechnology asked 20 experts including DNA2.0's Jeremy Minshull for their views on the term 'synthetic biology'.
2009-11-18
Gene-makers form security coalition
2009-11-18
DNA2.0 together with all other relevant gene synthesis companies forms International Gene Synthesis Consortium (IGSC) and publish a harmonized screening protocol. Genetic Engineering News writes about the event.
2009-10-16
The Silicon Valley Business Journal talks to Jeremy (wearing Nicolay's lab coat) about H1N1, Venture Cap and gene synthesis. Also some very kind words from Austin Gurney at OncoMed and Tillman Gerngross at Adimab.
2009-09-04
GenomeWeb talks to DNA2.0 about software for gene design in the context of Jean Peccoud at VTI receiving a $1.4M grant for scaling up GenoCAD.
2009-09-01
Nature Biotech 2009 Preventing the misuse of gene synthesis. Minshull and Wagner. DNA2.0 President Jeremy Minshull and Geneart CEO Ralf Wagner comment on the Nouri & Chyba publication on proliferation-resistant biotechnology.
2009-08-31
DNA2.0's Claes Gustafsson is interviewed in Nature magazine regarding the ongoing efforts to standardize the select agent screening procedures among the gene synthesis vendors.
2009-07-17
DNA2.0's Jeremy Minshull talks about SBIR grants and how the funding allowed the company to develop its novel gene synthesis technology in the absence of venture capital.
2009-07-17
KQED Quest - Decoding Synthetic Biology: See Stanford's Drew Endy pipette and UCSF's Chris Voigt tear up books; and DNA2.0 making genes.
2009-04-09
Nature 2009 458:703. For anyone who ever said there's no such thing as a poetic gene. Gustafsson Correspondence to Nature regarding poetry in synthetic genomes.
2009-02-15
Genetic Engineering News 2009 29(4):44. Does offshoring put patents in jeopardy? Piracy of intellectual property remains major concern especially in gene manufacturing. Are your genes made in a country that respect patent rights?
2008-06-04
Swedish tech magazine Ny Teknik has an article about the gene synthesis technology and DNA2.0.
2008-02-01
Tech Closeup took their cameras to DNA2.0 where a thousand synthetic genes are being made and shipped each month.
2008-01-25
First Artificial Chromosome. Science magazine publishes study from Craig Venters team creating the first artificial chromosome. The publication discloses that a large part of the gene synthesis for the chromosome was performed by DNA2.0.
2008-01-24
The New York Times talk to DNA2.0's Jeremy Minshull and other leading scientists on the completion of the first artificial chromosome which DNA2.0 helped synthesize.
2007-09-12
How Do You Like Your Genes? Biofabs Take Orders. New York Times talks to DNA2.0's Jeremy Minshull and other gene synthesis vendors on the emerging market for synthetic genes.
2007-09-01
DNA2.0 President Jeremy Minshull and Operon CEO Patrick Weiss talk about the mutually beneficial partnership between the two companies.
2007-04-15
DNA2.0's bioinformatics toolbox is selected by Genetic Engineering News as Best Of The Web.
2007-04-09
A Plastic Wrapper Today Could Be Fuel Tomorrow. New York Times interviews DNA2.0 Jeremy Minshull and our academic collaborator Prof Richard Gross on the ongoing 'fuel-latent plastic' project funded by DARPA
2006-11-01
Synthetic gene firms evolve toward sustainable business? The opportunities in the emerging gene synthesis market is discussed. Charlie Schmidt from Nature Biotechnology interviews Jeremy Minshull from DNA2.0 as well as the CEOs from a few other gene synthesis companies and related venture capital
2006-05-25
Synthetic biologists try to calm fears. The Synthetic Biology 2.0 conference at Berkeley explored the recent advances in synthetic biology and biosecurity. DNA2.0 president Jeremy Minshull describes how DNA2.0 handles potentially toxic synthetic DNA fragments.
2006-02-01
Synthetic Biology is the main story in the Jan/Feb issue of Genome Technology. In one of the related stories the magazine asks DNA2.0 about the vendor perspective of gene synthesis. Read more in Genome Technology Volume 2006, Issue 1, Page 31.
2005-10-18
PBS Nova SCience Now: TV segment on Artificial Life. Any day now, scientists could announce that they have created life from scratch. This segment will take you inside the quest for man-made life-forms with scientists who are on the endeavor's cutting edge.
2005-03-01
PlanetGene is Cool Site of the Day. The www.PlanetGene.com online resource for optimized genes is selected as 'Cool Site of the Day' on Dec 6, 2004.
2005-03-01
Protein Expression Using Synthetic Genes. tutorial on using synthetic genes for codon optimization and heterologous protein expression. Read more in genetic Engineering News Volume 25, Issue 5, page 32.
2004-12-03
Der Krieg soll grüner werden (A Greener War). Pentagon wants to minimize the environmental impact of its land based military operations and at the same time access the energy of its plastic trash in the form of fuel. DARPA grant to DNA2.0 and Dr. Richard Gross of Polytechnic University (Brooklyn, NY)
2004-11-15
Codon-Optimized Genes. DNA2.0 released PlanetGene, an online catalog to bridge the gap in protein expression between databases and experimentation. Read more in Genetic Engineering News Volume 24, Issue 20, Page 19.
2004-10-13
Interview with Dr. Jeremy Minshull, President of DNA2.0. Interview with the president of DNA2.0 including discussions on state-of-the-art protein engineering technology, market development of custom gene synthesis and key applications for synthetic biology.
2004-10-04
U.S. Military Bioengineering Plastic Fuels. DARPA is interested in tapping into the waste generated by the military's refuse as an on-site fuel source using the technology developed by DNA2.0 in Menlo Park, CA and Prof Richard Gross in Polytechnic Univ Brooklyn, NY.
2004-03-06
DNA Spirals Into Artist's Medium. DNA2.0, tomatoes, Descartes and Deep Blue's 36th move against Kasparov. One morning we'll wake up and the entire article will make sense (except the part about the glowing bunny).

Events

Apr
22
Swiss BioTech Days
April 22-23 2024
Basel, Switzerland
  Connect
Claes Gustafsson
May
13
PEGS Boston
May 13-17 2024
Boston, MA
  Connect
Claes Gustafsson
Jun
4
Antibody Engineering & Therapeutics
June 4-6 2024
London, UK
  Connect
Claes Gustafsson
Jun
23
ESACT
June 23-26 2024
Edinburgh, UK
  Connect
Claes Gustafsson
Sep
23
BPI East
September 23-26 2024
Boston, MA
  Connect
Claes Gustafsson
Oct
15
Festival of Biologics
October 15-17 2024
Basel, Switzerland
  Connect
Claes Gustafsson
Nov
5
PEGS Europe
November 5-7 2024
Barcelona, Spain
  Connect
Claes Gustafsson
Dec
15
Antibody Engineering & Therapeutics
December 15-19 2024
San Diego, CA
  Connect
Claes Gustafsson

Have a question?
Let's talk.

ATUM customer support scientists are available to discuss cloning strategies, gene design constraints, bioinformatics analyses, and other molecular biology/biotechnology concerns.

Call

Corporate Headquarters
(Newark, California)
+1 650 853 8347

Email

We generally reply within a few hours.

info@atum.bio